Saturday 17 October 2026
Export ZVSA’s income statement to Excel — free account
ZyVersa Therapeutics, Inc.
ZVSA Healthcare Biotechnology
In the quarter to March 2026, EPS grew 69.9% and free cash flow grew 54.9%, each against the same quarter a year earlier.
0.05
0.00
0.00%
Follow ZVSA
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Mar '26 | Dec '25 | Sep '25 | Jun '25 | Older periods | |
|---|---|---|---|---|---|
Cash and Short Term Investments |
0.30 | 0.10 | 0.53 | 0.07 |
+8 more quarters Free account |
Other current assets |
— | 0.01 | 0.17 | 0.10 | |
Total current assets |
0.74 | 0.46 | 1.00 | 0.55 | |
Goodwill and Intangible Assets (Total) |
— | — | — | 18.65 | |
Long-term assets (Other) |
— | — | — | 0.07 | |
Total non-current assets |
— | — | 0.04 | 19.09 | |
Total Assets |
0.74 | 0.46 | 1.04 | 19.64 | |
Notes Payable |
1.20 | — | — | — | |
Accounts Payable |
10.24 | 10.12 | 9.81 | 9.77 | |
Accrued Expenses |
3.30 | 2.73 | 2.96 | 2.92 | |
Other current liabilities |
0.13 | — | — | — | |
Total current liabilities |
14.87 | 12.85 | 12.77 | 12.69 | |
Long Term Tax Liability (Deferred) |
— | — | — | 0.85 | |
Total non-current liabilities |
— | — | — | 0.85 | |
Total liabilities |
14.87 | 12.85 | 12.77 | 13.54 | |
Additional Paid In Capital |
125.26 | 125.20 | 125.19 | 123.21 | |
Preferred Stock (Total) |
0.00 | 0.00 | 0.00 | 0.00 | |
Common Stock (Net) |
0.00 | 0.00 | 0.00 | 0.00 | |
Retained Earnings |
(139.38) | (137.58) | (136.91) | (117.10) | |
Treasury Stock |
0.01 | 0.01 | 0.01 | 0.01 | |
Common Equity (Total) |
(14.12) | (12.39) | (11.73) | 6.10 | |
Shareholders Equity (Total) |
(14.12) | (12.39) | (11.73) | 6.10 | |
Shareholders Equity and Liabilities (Total) |
0.74 | 0.46 | 1.04 | 19.64 | |
Shares (Common) |
8.10 | 8.10 | 8.10 | 4.87 | |
Shares (Preferred) |
0.01 | 0.01 | 0.01 | 0.01 | |
Shareholders Equity (Tangible) |
(14.12) | (12.39) | (11.73) | (12.55) | |
Net Debt |
(0.30) | (0.10) | (0.53) | (0.07) |
In millions of $ except per-share values · columns are period end dates